tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2023 Jan;29(1):226-228.
doi: 10.3201/eid2901.221514.
Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021
Stephanie J Curtis, Abdul W Shah, Ana Ratu, Donald J Wilson, Philip C Hill, Phil Hulcome, Cathy Gaylard, Daniel Faktaufon, Talica Cabemaiwai, Isireli Rabukawaqa, Tevita Qoriniasi, Akesh Narayan, Susana Nakalevu, Pablo Romakin, Jemesa Tudravu, James Fong, Nick Walsh
Abstract
During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.
Keywords: COVID-19; Fiji; Pacific Islands; SARS; SARS-CoV-2; antibodies; coronavirus; coronavirus disease; disease outbreak; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2023 Jan;29(1):226-228.
doi: 10.3201/eid2901.221514.
Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021
Stephanie J Curtis, Abdul W Shah, Ana Ratu, Donald J Wilson, Philip C Hill, Phil Hulcome, Cathy Gaylard, Daniel Faktaufon, Talica Cabemaiwai, Isireli Rabukawaqa, Tevita Qoriniasi, Akesh Narayan, Susana Nakalevu, Pablo Romakin, Jemesa Tudravu, James Fong, Nick Walsh
- PMID: 36573643
- DOI: 10.3201/eid2901.221514
Abstract
During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.
Keywords: COVID-19; Fiji; Pacific Islands; SARS; SARS-CoV-2; antibodies; coronavirus; coronavirus disease; disease outbreak; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.